Thermo Fisher Scientific and NCI launch myeloMATCH trial to advance AML and MDS treatment
In a significant advancement in cancer treatment, Thermo Fisher Scientific Inc. (NYSE: TMO) has partnered with the National Cancer Institute (NCI), a component of the ... Read More
Thermo Fisher opens new ultra-cold facility in Bleiswijk to expand clinical trial network
Thermo Fisher Scientific, a global leader in serving science, has unveiled its latest advancement in bioservices—a state-of-the-art ultra-cold facility located in Bleiswijk, Netherlands. This new ... Read More
Thermo Fisher Scientific achieves GMP approval in Italy for RNA-based products
In a significant advancement for the pharmaceutical and biotechnology industry, Thermo Fisher Scientific, a global leader in scientific services, has received Good Manufacturing Practice (GMP) ... Read More
Verici Dx signs licensing deal with Thermo Fisher for kidney rejection test
Verici Dx plc, a pioneer in clinical diagnostics for organ transplant, has announced an exclusive global licensing agreement with Thermo Fisher Scientific, a world leader ... Read More
Thermo Fisher Scientific launches Gibco OncoPro Tumoroid Culture Medium Kit
Fisher Scientific, a global leader in serving science, unveiled its latest product, the Gibco OncoPro Tumoroid Culture Medium Kit to expedite development of novel cancer ... Read More
Thermo Fisher Scientific opens new sterile drug facility in Singapore
Thermo Fisher Scientific has inaugurated a sterile drug facility in Singapore, in a move to enhance the ability of its customers to deliver novel medicines ... Read More
Thermo Fisher Scientific closes $2.8bn acquisition of Binding Site
Thermo Fisher Scientific, an American analytical laboratory instrument manufacturing company, has closed the previously announced acquisition of The Binding Site Group, a UK- based diagnostic ... Read More
Thermo Fisher to buy specialist protein diagnostics company Binding Site
Thermo Fisher Scientific has agreed to acquire The Binding Site Group, a UK-based specialist protein diagnostics company, for £2.25 billion ($2.6 billion) in an all-cash ... Read More
Moderna, Thermo Fisher sign manufacturing agreement for Spikevax vaccine
Moderna has entered into a 15-year collaboration agreement with Thermo Fisher Scientific to enable dedicated large-scale US manufacturing of Spikevax, the former’s Covid-19 vaccine as ... Read More
Thermo Fisher to acquire clinical research services provider PPD for $21bn
Thermo Fisher Scientific has agreed to acquire PPD, a US-based clinical research services provider, for $47.50 per share or $20.9 billion. The consideration includes assumption ... Read More